Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Johnson and Johnson
Boehringer Ingelheim
Medtronic
Cantor Fitzgerald
US Army
Chubb
Baxter
Queensland Health

Generated: April 19, 2018

DrugPatentWatch Database Preview

ANTIVERT Drug Profile

« Back to Dashboard

When do Antivert patents expire, and when can generic versions of Antivert launch?

Antivert is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in ANTIVERT is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.
Drug patent expirations by year for ANTIVERT
Pharmacology for ANTIVERT
Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Medical Subject Heading (MeSH) Categories for ANTIVERT
Synonyms for ANTIVERT
(.+/-.)-Meclizine
(+-)-Meclizine
(R)-Meclizine
1-((4-Chlorophenyl)(phenyl)methyl)-4-(3-methylbenzyl)piperazine
1-((4-Chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)piperazine
1-(p-Chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)piperazine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)diethylenediamine
1-(p-Chlorobenzhydryl)-4-(m-methylbenzyl)piperazine
1-[(4-chlorophenyl)-phenyl-methyl]-4-(m-tolylmethyl)piperazine
1-[(4-chlorophenyl)-phenylmethyl]-4-[(3-methylphenyl)methyl]piperazine
1-[(4-Chlorophenyl)(phenyl)methyl]-4-(3-methylbenzyl)piperazine
1-[(4-Chlorophenyl)(phenyl)methyl]-4-(3-methylbenzyl)piperazine #
1-[(4-chlorophenyl)(phenyl)methyl]-4-[(3-methylphenyl)methyl]piperazine
1-p-Chlorobenzhydryl-4-m-methylbenzylpiperazine
1104-22-9 (di-hydrochloride)
189298-48-4
36236-67-6 (hydrochloride)
569-65-3
AB00053493
AB00053493_14
AB00053493_15
AB1009566
AC1L1H9K
AC1Q2IO5
AK117759
AKOS015951354
AN-45986
Ancolan
Ancolon
Antivert (TN)
Antivert/25
Antivert/50
BDBM81467
Bonadettes
Bonadoxin
Bonadoxin (Salt/Mix)
Bonamine (Salt/Mix)
Bonamine (TN)
Bonine
Bonine (TN)
BPBio1_000588
BRD-A50311610-300-05-4
BRN 0332002
BSPBio_000534
BSPBio_001949
C07116
Calmonal
CAS_569-65-3
CHEBI:6709
CHEMBL1623
Chiclida
CTK6G9296
D08163
D0T1XW
DB00737
Diadril
Diadril (Salt/Mix)
DivK1c_000407
Dramamine II
DTXSID0023242
EINECS 209-323-3
EN300-58334
FT-0659103
GTPL2757
HE066292
HE354246
HE390639
Histamethine
Histamethizine
Histametizine
Histametizyn
Histametizyne
HSDB 3113
IDI1_000407
Itinerol
KB-212297
KBio1_000407
KBio2_001371
KBio2_003939
KBio2_006507
KBio3_001449
KBioGR_000473
KBioSS_001371
L001136
LS-111206
Marex
MCULE-7463916552
Meclicot
meclizine
Meclizine [INN:BAN]
Meclizine Hcl
Meclizine hydrochloride
Meclozin
Meclozina
Meclozina [INN-Spanish]
Meclozine
Meclozine (BAN)
Meclozinum
Meclozinum [INN-Latin]
Medivert
MolPort-002-069-043
Monamine
Navicalm
NCGC00018296-02
NCGC00018296-04
NCGC00018296-08
Neo-istafene
Neo-suprimal
Neo-suprimel
Nevidoxine
Nevidoxine (TN)
NINDS_000407
NSC 169189
NSC_4034
NSC-169189
NSC169189
OCJYIGYOJCODJL-UHFFFAOYSA-N
Parachloramine
Peremesin
Piperazine, 1-((4-chlorophenyl)phenylmethyl)-4-((3-methylphenyl)methyl)-
Piperazine, 1-(p-chloro-.alpha.-phenylbenzyl)-4-(m-methylbenzyl)-
Piperazine, 1-(p-chloro-alpha-phenylbenzyl)-4-(m-methylbenzyl)-
Piperazine, 1-[(4-chlorophenyl)phenylmethyl]-4-[(3-methylphenyl)methyl]-
Postafen (TN)
Postafene
Prestwick0_000457
Prestwick1_000457
Prestwick2_000457
Prestwick3_000457
Ravelon
Ru-Vert-M
Sabari
SBI-0051433.P003
SC-51103
SCHEMBL4649
Sea-Legs
Siguran
SPBio_000100
SPBio_002473
Spectrum_000891
Spectrum2_000110
Spectrum3_000485
Spectrum4_000037
Spectrum5_000919
Subari
Suprimal
Travelon
U. C. B. 5062
U.C.B. 5062
UCB 170
UCB 5052
UCB 5062
Veritab
Vertizine (Salt/Mix)
Vomisseis
Vomissels
WLN: T6N DNTJ AYR&R DG& D1R C1
Z53003552

US Patents and Regulatory Information for ANTIVERT

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET, CHEWABLE;ORAL 010721-005 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-001 Jan 20, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Casper Pharma Llc ANTIVERT meclizine hydrochloride TABLET;ORAL 010721-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
Queensland Health
Daiichi Sankyo
Merck
Argus Health
Cerilliant
Healthtrust
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.